ClinVar Miner

Variants studied for maple syrup urine disease type 2

Included ClinVar conditions (1):
Minimum submission review status: Collection method:
Minimum conflict level:
Gene type:
ClinVar version:

If a variant has more than one submission, it may be counted in more than one significance column. If this is the case, the total number of variants will be less than the sum of the other cells.

pathogenic likely pathogenic uncertain significance likely benign benign total
18 7 4 0 0 29

Gene and significance breakdown #

Total genes and gene combinations: 1
Download table as spreadsheet
Gene or gene combination pathogenic likely pathogenic uncertain significance total
DBT 18 7 4 29

Submitter and significance breakdown #

Total submitters: 9
Download table as spreadsheet
Submitter pathogenic likely pathogenic uncertain significance total
OMIM 12 0 0 12
Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center 2 5 2 9
Laboratory of Medical Genetics, National & Kapodistrian University of Athens 1 2 0 3
Ege University Pediatric Genetics, Ege University 1 0 1 2
Genetic Services Laboratory, University of Chicago 1 0 0 1
Centogene AG - the Rare Disease Company 1 0 0 1
Knight Diagnostic Laboratories, Oregon Health and Sciences University 1 0 0 1
DASA 1 0 0 1
clinical biochemical genetics laboratory, stanford university 0 0 1 1

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.